Table 1.
Characteristic | Number of Patients (Total 94) |
---|---|
Age (years) | |
Mean (±SD) | 67.25 (10.25) |
Gender | |
Males | 63 (67.7%) |
Females | 31 (32.3%) |
Treatment Status | |
Treatment-naive | 20 (21.3%) |
Previously treated | 74 (78.7%) |
Total number of prior injections in switch therapy group | |
Mean (±SD) | 8.63 (4.74) |
Total number of IVI brolucizumab per patient | |
Mean (±SD) | 1.36 (± 0.58) |
Interval between IVI brolucizumab in weeks | |
Mean (±SD) | 10.2 ± 2.1 |
Abbreviations: SD, standard deviation; IVI, intravitreal injection.